| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Miller Mary | Chief Legal Officer | C/O ACRIVON THERAPEUTICS, INC., 480 ARSENAL WAY, SUITE 100, WATERTOWN | /s/ Adam D. Levy, Attorney-in-Fact | 18 Feb 2026 | 0001841088 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ACRV | Common Stock | Tax liability | $354 | -217 | -0.64% | $1.63 | 33,679 | 14 Feb 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. |